Live Breaking News & Updates on President Pharma Research

Stay updated with breaking news from President pharma research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sebi bans Wockhardt's former executive from securities market for 6 months | Business News,The Indian Express

Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules. ....

Huzaifa Khorakiwala , Murtaza Khorakiwala , Pharma Research , Regulatory Affairs At Wockhardt , Drug Administration , President Pharma Research , Quality Control , Regulatory Affairs , Habil Khorakiwala ,

Sebi bans Wockhardt's former executive from securities market for 6-month for insider trading

Sebi bans Wockhardt's former executive from securities market for 6-month for insider trading
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Huzaifa Khorakiwala , Murtaza Khorakiwala , Yatendra Kumar , Exchange Board Of India Sebi , Drug Administration , Pharma Research , Wockhardt Ltd , Regulatory Affairs At Wockhardt , Exchange Board , President Pharma Research , Quality Control , Regulatory Affairs , Habil Khorakiwala ,

Sebi bans Wockhardt's former executive from securities market for 6-month for insider trading

Sebi bans Wockhardt's former executive from securities market for 6-month for insider trading
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

New Delhi , Yatendra Kumar , Murtaza Khorakiwala , Huzaifa Khorakiwala , Wockhardt Ltd , Drug Administration , Regulatory Affairs At Wockhardt , Pharma Research , Exchange Board Of India Sebi , Exchange Board , President Pharma Research , Quality Control , Regulatory Affairs , Habil Khorakiwala ,